Ista Pharmaceuticals, Inc. (ISTA) – FDA
-
ISTA Pharma (ISTA) Reports Positive Results from BEPOSONE Phase 2
-
ISTA Pharma (ISTA) Reports Positive Results from Phase 3 Study of PROLENSA, to File New NDA in 1H'12
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to ISTA Stock Lookup